We are live on ! Find out more
LXRX icon

Lexicon Pharmaceuticals
LXRX

137 hedge funds and large institutions have $1.41B invested in Lexicon Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 33

15% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 20

1% more funds holding

Funds holding: 135 → 137 (+2)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.4% less ownership

Funds ownership: 109.14% → 108.74% (-0.4%)

25% less capital invested

Capital invested by funds: $1.89B → $1.41B (-$478M)

88% less call options, than puts

Call options by funds: $1.77M | Put options by funds: $14.2M

Holders
137
Holders Change
+2
Holders Change %
+1.48%
% of All Funds
3.42%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
23
Increased
44
Reduced
33
Closed
20
Calls
$1.77M
Puts
$14.2M
Net Calls
-$12.4M
Net Calls Change
-$26.6M

Top Buyers

1
KCM
Kornitzer Capital Management
Kansas
+$11.3M
2
Bank of America
Bank of America
North Carolina
+$6.06M
3
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$5.18M
4
VOYA Investment Management
VOYA Investment Management
Georgia
+$4.15M
5
PA
Pinnacle Associates
New York
+$2.69M

Top Sellers

1
Norges Bank
Norges Bank
Norway
-$12.5M
2
KCM
Kingdon Capital Management
New York
-$7.96M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$5.61M
4
Millennium Management
Millennium Management
New York
-$4.56M
5
CCI
Columbus Circle Investors
-$3.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
51
Paloma Partners
Connecticut
$854K +$137K +9,307 +15%
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$849K -$107K -7,233 -9%
Russell Investments Group
53
Russell Investments Group
United Kingdom
$827K -$66.1K -4,479 -6%
KCM
54
Kingdon Capital Management
New York
$824K -$7.96M -539,355 -89%
CS
55
Credit Suisse
Switzerland
$798K -$37.3K -2,527 -4%
Citadel Advisors
56
Citadel Advisors
Florida
$788K -$688K -46,620 -42%
ProShare Advisors
57
ProShare Advisors
Maryland
$767K +$68K +4,604 +8%
CG
58
Cutler Group
California
$764K +$909K +61,572 +9,651%
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
$684K – – –
T. Rowe Price Associates
60
T. Rowe Price Associates
Maryland
$660K +$304K +20,600 +62%
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
$624K +$18.6K +1,260 +3%
GCP
62
GSA Capital Partners
United Kingdom
$624K +$459K +31,100 +158%
Susquehanna International Group
63
Susquehanna International Group
Pennsylvania
$554K -$5.61M -379,761 -89%
Simplex Trading
64
Simplex Trading
Illinois
$523K +$629K +42,616 New
Northwestern Mutual Wealth Management
65
Northwestern Mutual Wealth Management
Wisconsin
$521K -$7.38K -500 -1%
MCC
66
Malaga Cove Capital
California
$521K +$638K +43,189 New
Barclays
67
Barclays
United Kingdom
$471K +$120K +8,123 +27%
DCM
68
Dupont Capital Management
Delaware
$445K – – –
UOTTAIMCU
69
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$439K – – –
Manulife (Manufacturers Life Insurance)
70
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$436K -$15.1K -1,020 -3%
RJA
71
Raymond James & Associates
Florida
$416K -$15.1K -1,025 -3%
MLICM
72
Metropolitan Life Insurance Company (MetLife)
New York
$408K – – –
D.E. Shaw & Co
73
D.E. Shaw & Co
New York
$389K -$1.24M -83,635 -73%
State of Wisconsin Investment Board
74
State of Wisconsin Investment Board
Wisconsin
$381K – – –
FRM
75
Fox Run Management
Connecticut
$376K +$452K +30,600 New
1 2
3
4 5

LXRX Hedge Fund Activity: Q3 2017 in Review

137 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q3 2017, worth a combined $1.41B — down 25% from $1.89B a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new LXRX positions and 20 closed out — a net gain of 3 holders — while 44 added to existing stakes and 33 trimmed.

The largest buyer was Kornitzer Capital Management, opening a new position worth an estimated $11.3M. The largest seller was Norges Bank, cutting an estimated $12.5M.

  • 137 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q3 2017, up from 135 in Q2 2017.
  • Funds reported $1.41B of Lexicon Pharmaceuticals stock for Q3 2017, down 25% quarter-over-quarter.
  • 23 funds opened new Lexicon Pharmaceuticals positions in Q3 2017 and 20 closed out, a net change of +3 holders.
  • The largest Lexicon Pharmaceuticals buyer in Q3 2017 was Kornitzer Capital Management, an estimated $11.3M added.
  • The largest Lexicon Pharmaceuticals seller in Q3 2017 was Norges Bank, an estimated $12.5M sold.

Based on aggregated 13F filings for Q3 2017.